StockData
Medtronic plc logo

Medtronic plc (MDT) shareholders

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/303% above fair value
$102.32−0.56 (-0.54%)

Close on Nov 17, 2026Market cap $130.88BP/E 25.1Yield 2.78%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
86.5%
1.11B of 1.28B shares
Institutional holders
2,126
169 new, 244 sold out
Net institutional buying
15M
In Q2 2026
Insider trades, 12 months
0 buys · 18 sales
Net sold $14.67M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Vanguard Capital Management96,424,0447.51%13G (passive)Mar 31, 2026
BlackRock, Inc.88,655,5856.90%13G (passive) amendmentMar 31, 2025
State Street Corporation66,055,9695.20%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MDTValueChange% of portfolio
BlackRock, Inc.114,020,7878.91%$8.92B+838,2200.13%
Vanguard Capital Management LLC83,816,7356.55%$6.56B+482,9020.14%
State Street Corp63,399,3154.96%$5.01B+1,658,3010.15%
Vanguard Portfolio Management LLC34,059,9672.66%$2.66B+609,4090.12%
Geode Capital Management, LLC30,192,0152.36%$2.35B+1,455,6740.13%
JPMorgan Chase & Co27,784,4712.17%$2.25B−23,189,0700.12%
First Eagle Investment Management, LLC27,567,9662.16%$2.16B+17,523,2711.79%
Bank Of America Corp /De/21,322,4011.67%$1.67B−4,692,6020.11%
Massachusetts Financial Services Co /Ma/19,872,6001.55%$2.61B−1,564,9990.83%
Morgan Stanley19,444,8711.52%$1.52B−1,272,1580.08%
Deutsche Bank AG\18,449,8771.44%$1.44B−552,5370.42%
Invesco Ltd.17,885,1501.40%$1.40B+1,098,1520.11%
Franklin Resources Inc17,550,9831.37%$1.37B+3,375,3040.30%
Norges Bank16,551,0161.29%$1.29BNew0.13%
Royal Bank of Canada16,026,4751.25%$1.25B+1,846,6580.19%
Bank of New York Mellon Corp14,694,2531.15%$1.15B−807,6160.19%
Capital Research Global Investors13,261,3101.04%$1.04B−28,665,2800.14%
Arrowstreet Capital, Limited Partnership12,892,7101.01%$1.01B+8,233,2850.45%
Northern Trust Corp11,626,7410.91%$909.56M−410,0800.11%
Ameriprise Financial Inc11,565,9880.90%$904.73M−413,9430.18%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20262,1261.11B86.5%169 / 848916 / 244143M127M
Q1 20262,2391.09B85.6%185 / 904893 / 211214M84M
Q4 20252,3061.10B85.8%291 / 879880 / 10869M95M
Q3 20252,1711.13B88.2%190 / 917816 / 127123M90M
Q2 20252,1391.09B85.6%147 / 880876 / 14775M58M
Q1 20252,1671.08B84.4%209 / 940799 / 12677M61M
Q4 20242,1181.07B83.5%247 / 787885 / 15480M84M
Q3 20242,0561.08B84.6%180 / 756902 / 116175M70M
Q2 20242,0161.09B85.2%141 / 822835 / 16233M121M
Q1 20242,0651.18B92.4%176 / 929726 / 14890M44M
Q4 20232,0661.14B89.1%272 / 647986 / 135104M55M
Q3 20231,9591.09B85.4%116 / 916732 / 17341M36M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

366 funds held MDT in Q2 2026, 65% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MDTValue% of fundAs of
Vanguard Total Stock Market Index Fund40,757,4223.19%$3.19B0.14%Jun 30, 2026
Vanguard 500 Index Fund33,271,4572.60%$2.60B0.16%Jun 30, 2026
Vanguard Value Index Fund12,221,6430.96%$956.10M0.38%Jun 30, 2026
Vanguard Dividend Appreciation Index Fund7,264,1590.57%$620.29M0.47%Jul 31, 2026
Vanguard Institutional Index Fund6,970,0040.54%$545.26M0.16%Jun 30, 2026
Dodge & Cox Stock Fund5,743,9000.45%$449.35M0.38%Jun 30, 2026
Vanguard Windsor Ii Fund5,314,1180.42%$453.77M0.68%Jul 31, 2026
Vanguard High Dividend Yield Index Fund5,164,3240.40%$440.98M0.44%Jul 31, 2026
WCM Focused International Growth Fund4,354,5300.34%$340.65M1.51%Jun 30, 2026
Vanguard Health Care Fund4,228,1280.33%$361.04M0.95%Jul 31, 2026
Vanguard Health Care Index Fund3,849,5680.30%$284.14M1.50%May 31, 2026
iShares Russell 1000 Value ETF2,864,8020.22%$224.11M0.28%Jun 30, 2026
Invesco S&P 500 Equal Weight ETF2,321,6070.18%$198.24M0.21%Jul 31, 2026
Invesco Value Opportunities Fund2,314,9220.18%$197.67M2.17%Jul 31, 2026
Equity Income Fund1,925,7220.15%$150.65M2.33%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Geoffrey MarthaChairman and CEO, Director277,8660.02%Oct 16, 2026
Michael MarinaroPresident113,3530.01%Nov 4, 2026
Harry Skip KiilEVP & President Cardiovascular42,1860.00%Sep 17, 2026
Denise L. BlomquistChief Accounting Officer16,3980.00%Sep 16, 2026
Kweli ThompsonEVP & President, Neuroscience35,3900.00%Aug 4, 2026
Michelle QuinnEVP, GC and Secretary26,7210.00%Aug 4, 2026
Matthew R. WalterSVP, Chief HR Officer39,9280.00%Aug 4, 2026
Thierry PietonEVP & Chief Financial Officer49,6450.00%Aug 4, 2026
Brett A. WallEVP & Pres Neuroscience82,1830.01%May 28, 2026
Gregory L. SmithEVP Global Ops & Supply Chain51,8300.00%Nov 21, 2025
Gary Louis CoronaInterim CFO44,2550.00%Jan 23, 2025
Ivan K. FongEVP GENERAL COUNSEL & SECR54,6920.00%Dec 17, 2024
Sean SalmonEVP & President Cardiovascular64,7220.01%Dec 17, 2024
Jennifer M. KirkChief Accounting Officer28,0110.00%Dec 10, 2024
Kevin E. LoftonDirector9,9770.00%Oct 21, 2026
Joon Sup LeeDirector1,8030.00%Apr 29, 2026
Craig ArnoldDirector42,1850.00%Apr 29, 2026
William R. JellisonDirector6,4440.00%Apr 29, 2026
Scott C. DonnellyDirector23,9240.00%Apr 29, 2026
Randall J. HoganDirector86,0820.01%Apr 29, 2026
Kendall J. PowellDirector54,3800.00%Apr 29, 2026
Lidia FonsecaDirector7,6440.00%Apr 29, 2026
Elizabeth G. NabelDirector19,5840.00%Apr 29, 2026
John P. GroetelaarsDirector1,4440.00%Apr 29, 2026
Gregory P. LewisDirector5,7540.00%Apr 29, 2026
Andrea Jo GoldsmithDirector10,2470.00%Apr 30, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Michael Marinaro
President
Nov 2, 2026Award+6,547––113,353
Kevin E. Lofton
Director
Oct 15, 2026Other−182––9,977
Michael Marinaro
EVP, Pres MedSurg and Americas
Oct 15, 2026Sale(10b5-1 plan)−10,420$96.00$1.00M105,916
Geoffrey Martha
Chairman and CEO, Director
Oct 15, 2026Sale(10b5-1 plan)−50,000$95.00$4.75M277,866
Harry Skip Kiil
EVP & President Cardiovascular
Sep 16, 2026Sale−1,483$93.65$138.88K42,186
Denise L. Blomquist
Chief Accounting Officer
Sep 15, 2026Gift−600––16,398
Michael Marinaro
EVP, Pres MedSurg and Americas
Aug 20, 2026Tax withholding−1,084$92.30$100.05K116,336
Denise L. Blomquist
Chief Accounting Officer
Aug 3, 2026Award+2,337––16,998
Michael Marinaro
EVP, Pres MedSurg and Americas
Aug 3, 2026Award+10,960––71,273
Michael Marinaro
EVP, Pres MedSurg and Americas
Aug 3, 2026Award+46,147––117,420
Thierry Pieton
EVP & Chief Financial Officer
Aug 3, 2026Award+11,537––49,645
Michelle Quinn
EVP, GC and Secretary
Aug 3, 2026Award+6,346––26,721
Harry Skip Kiil
EVP & President Cardiovascular
Aug 3, 2026Award+9,230––43,669
Matthew R. Walter
SVP, Chief HR Officer
Aug 3, 2026Award+5,769––39,928
Geoffrey Martha
Chairman and CEO, Director
Aug 3, 2026Award+41,533––327,866
Kweli Thompson
EVP & President, Neuroscience
Aug 3, 2026Award+6,923––35,390
Denise L. Blomquist
Chief Accounting Officer
Jul 31, 2026Tax withholding−212$85.39$18.10K14,661
Michael Marinaro
EVP, Pres MedSurg and Americas
Jul 31, 2026Tax withholding−3,356$85.39$286.57K60,313
Harry Skip Kiil
EVP & President Cardiovascular
Jul 31, 2026Tax withholding−3,074$85.39$262.49K34,439
Matthew R. Walter
SVP, Chief HR Officer
Jul 31, 2026Tax withholding−1,675$85.39$143.03K34,159
Geoffrey Martha
Chairman and CEO, Director
Jul 31, 2026Tax withholding−15,810$85.39$1.35M286,333
Kweli Thompson
EVP & President, Neuroscience
Jul 31, 2026Tax withholding−1,739$85.39$148.49K28,467
Michelle Quinn
EVP, GC and Secretary
Jul 28, 2026Tax withholding−2,069$86.88$179.75K20,375
Matthew R. Walter
SVP, Chief HR Officer
Jul 8, 2026Sale(10b5-1 plan)−3,102$83.15$257.93K35,694
Harry Skip Kiil
EVP & President Cardiovascular
Jun 8, 2026Sale−3,961$80.44$318.62K37,455
Harry Skip Kiil
EVP & President Cardiovascular
Jun 8, 2026Sale−228$80.45$18.34K37,227
Denise L. Blomquist
Chief Accounting Officer
Jun 5, 2026Tax withholding−237$83.32$19.75K14,737
Michael Marinaro
EVP, Pres MedSurg and Americas
Jun 4, 2026Tax withholding−7,471$83.32$622.48K63,122
Geoffrey Martha
Chairman and CEO, Director
Jun 4, 2026Tax withholding−41,936$83.32$3.49M301,163
Harry Skip Kiil
EVP & President Cardiovascular
Jun 4, 2026Tax withholding−6,817$83.32$567.99K41,416
Matthew R. Walter
SVP, Chief HR Officer
Jun 4, 2026Tax withholding−2,840$83.32$236.63K38,689
Denise L. Blomquist
Chief Accounting Officer
May 26, 2026Option exercise+1,712––14,974
Michael Marinaro
EVP, Pres MedSurg and Americas
May 26, 2026Option exercise+18,994––70,593
Geoffrey Martha
Chairman and CEO, Director
May 26, 2026Option exercise+94,963––343,099
Brett A. Wall
EVP & Pres Neuroscience
May 26, 2026Option exercise+26,907––82,183
Harry Skip Kiil
EVP & President Cardiovascular
May 26, 2026Option exercise+15,195––48,233
Matthew R. Walter
SVP, Chief HR Officer
May 26, 2026Option exercise+9,149––41,529
Matthew R. Walter
SVP, Chief HR Officer
May 1, 2026Tax withholding−35$80.00$2.80K32,380
Lidia Fonseca
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K7,644
Gregory P. Lewis
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K5,754
Kendall J. Powell
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K51,380
Kevin E. Lofton
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K10,140
Elizabeth G. Nabel
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K19,584
Randall J. Hogan
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K48,998
Denise L. Blomquist
Chief Accounting Officer
Apr 28, 2026Tax withholding−318$81.90$26.04K13,262
Craig Arnold
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K42,185
Scott C. Donnelly
Director
Apr 28, 2026Tax withholding−207$81.90$16.95K23,679
Lidia Fonseca
Director
Apr 27, 2026Award+2,111––7,851
William R. Jellison
Director
Apr 27, 2026Award+1,444––6,444
Gregory P. Lewis
Director
Apr 27, 2026Award+2,111––5,961
Kendall J. Powell
Director
Apr 27, 2026Award+2,111––51,587
Kevin E. Lofton
Director
Apr 27, 2026Award+2,111––10,347
Elizabeth G. Nabel
Director
Apr 27, 2026Award+2,111––19,791
Randall J. Hogan
Director
Apr 27, 2026Award+2,111––49,205
Denise L. Blomquist
Chief Accounting Officer
Apr 27, 2026Award+1,508––13,580
Craig Arnold
Director
Apr 27, 2026Award+2,111––42,392
Joon Sup Lee
Director
Apr 27, 2026Award+1,803––1,803
Scott C. Donnelly
Director
Apr 27, 2026Award+2,111––23,886
John P. Groetelaars
Director
Apr 27, 2026Award+1,444––1,444
Thierry Pieton
EVP & Chief Financial Officer
Mar 3, 2026Tax withholding−2,976$96.71$287.81K37,574

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.80%
23M shares short
Days to cover
1.9
At 12M shares a day
Change since last report
-83.5%
From 139M shares
Short volume, 20 days
42.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Medtronic's stock actually held short. Settlement fails (shares not delivered on time) peaked at 133,982 shares on Oct 5, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Geoffrey Martha
Officer, Director
Oct 15, 202650,000$4.75MOct 15, 2026Restricted Stock Vesting
Michael Marinaro
Officer
Oct 15, 202610,420$1.00MOct 15, 2026ESPP Purchase
Harry Skip Kiil
Officer
Sep 16, 20261,483$138.89KSep 16, 2026Restricted Stock Vesting
Matthew R. Walter
Officer
Jul 8, 20263,102$257.93KJul 8, 2026ESPP Purchase
Harry Skip Kiil
Officer
Jun 8, 20264,189$336.97KJun 8, 2026Restricted Stock Vesting
Harry Skip Kiil
Officer
Feb 19, 202652,524$5.13MFeb 19, 2026Restricted Stock Vesting
Gregory L. Smith
Officer
Nov 19, 202530,000$3.06MNov 19, 2025ESPP Purchase
Harry Skip Kiil
Officer
Sep 3, 20258,605$788.05KSep 3, 2025Restricted Stock Vesting
Sean Salmon
Officer
Jun 6, 202518,378$1.60MJun 6, 2025Option Granted 08/03/2015
Brett A. Wall
Officer
Jan 24, 202512,437$1.12MJan 24, 2025Options Granted 08/03/2015
Brett A. Wall
Officer
Jan 8, 20259,850$792.04KJan 8, 2025Stock Option Exercise
Karen L. Parkhill
Former Director
Oct 31, 202430,000$2.69MOct 31, 2024Option Granted- 07/30/2018
Karen L. Parkhill
Former Director
Oct 30, 202415,000$1.36MOct 30, 2024Option Granted- 07/30/2018
Karen L. Parkhill
Former BOD
Oct 29, 202415,000$1.37MOct 29, 2024Option Granted - 07/30/2018
Karen L. Parkhill
Former Director
Oct 24, 202422,712$2.10MOct 24, 2024Options Granted 08/01/2016

Congress trades

40 trades in Medtronic reported by 17 members of the House

MemberTypeTradedAmountFiled
Kevin Hern
OK01 · joint account
SoldAug 24, 2026$15K–50KSep 1, 2026
Richard Dean Dr McCormick
GA06
SoldJul 30, 2026$1K–15KAug 14, 2026
Gilbert Cisneros
CA31
Sold (part)May 15, 2026$1K–15KJun 8, 2026
Kevin Hern
OK01 · joint account
SoldMar 20, 2026$15K–50KApr 3, 2026
Julie Johnson
TX32 · joint account
SoldDec 18, 2025$1K–15KJan 15, 2026
Julie Johnson
TX32 · joint account
Sold (part)Nov 13, 2025$1K–15KDec 11, 2025
Richard Dean Dr McCormick
GA06
BoughtNov 5, 2025$1K–15KDec 9, 2025
Julie Johnson
TX32 · joint account
Sold (part)Aug 14, 2025$1K–15KSep 11, 2025
Rob Bresnahan
PA08
BoughtMay 15, 2025$1K–15KMay 31, 2025
Jefferson Shreve
IN06
SoldMay 8, 2025$15K–50KJun 22, 2025
Julie Johnson
TX32 · joint account
Sold (part)May 7, 2025$1K–15KAug 5, 2026
455 days late
Rob Bresnahan
PA08
SoldApr 8, 2025$1K–15KApr 28, 2025
George Whitesides
CA27
SoldMar 24, 2025$50K–100KApr 23, 2025
Bruce Westerman
AR04
SoldMar 20, 2025$1K–15KApr 16, 2025
Bruce Westerman
AR04
BoughtMar 4, 2025$1K–15KApr 16, 2025
Rob Bresnahan
PA08
BoughtFeb 25, 2025$1K–15KMar 27, 2025
Emily Randall
WA06 · spouse
SoldJan 6, 2025$1K–15KFeb 11, 2025
John James
MI10
SoldSep 4, 2024$1K–15KSep 6, 2024
Earl Blumenauer
OR03 · spouse
SoldJul 9, 2024$1K–15KAug 6, 2024
Kathy Manning
NC06 · spouse
Sold (part)Jul 2, 2024$1K–15KAug 16, 2024
John James
MI10
BoughtJun 18, 2024$1K–15KSep 2, 2024
76 days late
John James
MI10
Sold (part)Jun 3, 2024$1K–15KSep 2, 2024
91 days late
Kathy Manning
NC06 · spouse
BoughtJan 23, 2024$1K–15KFeb 6, 2024
Kathy Manning
NC06 · spouse
BoughtJan 23, 2024$15K–50KFeb 6, 2024
Kathy Manning
NC06 · spouse
BoughtJan 23, 2024$1K–15KFeb 6, 2024
Jared Moskowitz
FL23
SoldDec 28, 2023$1K–15KAug 21, 2024
237 days late
Jared Moskowitz
FL23 · child
SoldDec 28, 2023$1K–15KJan 22, 2024
Jared Moskowitz
FL23 · child
SoldDec 28, 2023$1K–15KJan 22, 2024
Kathy Manning
NC06 · spouse
SoldDec 12, 2023$1K–15KJan 12, 2024
Kathy Manning
NC06 · spouse
SoldDec 12, 2023$15K–50KJan 12, 2024
Kathy Manning
NC06 · spouse
SoldDec 12, 2023$1K–15KJan 12, 2024
Debbie Dingell
MI06
BoughtDec 5, 2023$15K–50KDec 14, 2023
John James
MI10
BoughtNov 10, 2023$1K–15KSep 2, 2024
297 days late
Greg Stanton
AZ04 · spouse
SoldOct 24, 2023$1K–15KNov 9, 2023
Greg Stanton
AZ04 · spouse
BoughtSep 26, 2023$1K–15KNov 9, 2023
Michael Patrick Guest
MS03 · spouse
BoughtAug 7, 2023$1K–15KAug 23, 2023
Pete Sessions
TX17 · spouse
SoldJun 15, 2023$15K–50KJun 26, 2023
Kathy Manning
NC06 · spouse
BoughtApr 28, 2023$1K–15KMay 19, 2023
Kathy Manning
NC06
BoughtApr 28, 2023$1K–15KMay 19, 2023
Richard Dean Dr McCormick
GA06
BoughtMar 15, 2023$1K–15KSep 17, 2025
917 days late

See a number that looks wrong?